CD4 and neoplasm: The early observation that CTLA‐4 blockade could enhance tumor Ag‐specific CD4+ T cell priming but could not overcome the eventual tolerization of these cells highlighted the contribution of alternative pathways to the regulation of T lymphocyte function.125